TABLE 4.
Clinical trials (http://clinicaltrials.gov/).
| Clinical Trials.gov number | Conditions/diseases | Drugs | Intervention/treatment | Enrollment | Phase |
|---|---|---|---|---|---|
| *Unregistered Bang et al. (2011), Bang et al. (2012) | CP and fat malabsorption | Cholecalciferol | Cholecalciferol 1520 IU daily and calcium 800 mg weekly for 10 weeks, PO | 30 | Not applicable |
| *NCT00956839 Reddy et al. (2013) | TCP | Cholecalciferol | 3,00,000/6,00,000 Units single dose, IM | 40 | VI |
| NCT02965898 | CP | VD | 100/10 μg daily for at least 7 years, PO | 260 | Not applicable |
| NCT01141998 | CP with malabsorption syndromes | Calcium | 400 mg two times daily week 0–10 and week 14–52, PO | 27 | Not applicable |
| NCT02108509 | CP with osteopenia/osteoporosis | Not applicable | Not applicable | 55 | Not applicable |
CP, chronic pancreatitis; TCP, tropical calcific pancreatitis; PO, oral intake; IM, intramuscular injection; VD, vitamin D.